LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
0,95Â US$
arrow_upward
+1,03%(+0,0097) 1D
0,96Â US$
arrow_upward
+1,18% (+0,011)bedtimeJashtë orarit
Mbyllur: 7 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për LCTX...
Hap
0,94Â US$
I lartë
0,96Â US$
I ulët
0,92Â US$
Kapitalizimi i tregut
239,12Â mln
Vëllimi mesatar
1,35Â mln
Vëllimi
1,48Â mln
Maksimumi 52-javor
2,09Â US$
Minimumi 52-javor
0,88Â US$
Fitimet për aksion
-0,14Â US$
Beta
1,60
Aksionet në qarkullim
252,91Â mln
Numri i punonjësve
75
Hap
0,94Â US$
I lartë
0,96Â US$
I ulët
0,92Â US$
Kapitalizimi i tregut
239,12Â mln
Vëllimi mesatar
1,35Â mln
Vëllimi
1,48Â mln
Maksimumi 52-javor
2,09Â US$
Minimumi 52-javor
0,88Â US$
Fitimet për aksion
-0,14Â US$
Beta
1,60
Aksionet në qarkullim
252,91Â mln
Numri i punonjësve
75
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
MarketBeat
·
5 minuta më parë
Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above Two Hundred Day Moving Average - Here's Why
Simply Wall Street
·
42 minuta më parë
European Expansion Might Change The Case For Investing In Xometry (XMTR)
Investing.com
·
11 minuta më parë
Nasdaq Elliott Wave: Incomplete Impulse or Bearish Island Gap?
Yahoo Finance
·
1 orë më parë
Stock Market: Will S&P 500 Open Up or Down Today?
Profili
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Rreth Lineage Cell Therapeutics Inc